Grab Holdings Ltd. vs MiniMed Group Inc. Common Stock — how do they compare? Grab Holdings Ltd. trades at $3.13 (market cap $12.60B), while MiniMed Group Inc. Common Stock trades at $19.55 (market cap $5.38B). The key difference: Grab Holdings Ltd. is far larger — about 2.3× MiniMed Group Inc. Common Stock's market cap, and MiniMed Group Inc. Common Stock is trading nearer its 52-week high, Grab Holdings Ltd. nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Grab Holdings Ltd. for 94 Days and MiniMed Group Inc. Common Stock for 0 Days on average.
| GRAB | MMED | |
|---|---|---|
Market Cap | $12.60B | $5.38B |
Volume | 87,608,440 | 9,619,294 |
Sector | Technology | Health |
52-Week High | $6.17 | $23.84 |
52-Week Low | $2.80 | $10.80 |
Typical Hold Time | 94 Days | 0 Days |
Enterprise Value | $8.33B | $5.18B |
Signals from Pluang's Aura AI — not financial advice
GRAB trades at $3.11, up 1.3% today, with a bearish technical signal but strong fundamentals including a 22% YoY revenue growth in Q2 2026 and a net income margin of 16.03%. Recent news highlights a $30 million CEO share purchase and the acquisition of a 60% stake in Atome Financial for $1.49 billion, signaling confidence and expansion in financial services.
The outlook is positive with robust earnings beats and a 91.67% analyst buy rating, though risks include high capital expenditure, regional regulatory challenges, and volatile cash flows. The stock's current valuation at a P/E of 28 reflects growth expectations amid competitive pressures.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Grab Holdings Limited operates as a holding company. The Company, through its subsidiaries, develops delivery management, mobility, financial services, and enterprise software solutions. Grab Holdings serves customers worldwide.
Read more on GRAB →MiniMed develops, manufactures, and markets diabetes-management technologies. Its products include insulin-delivery systems, continuous glucose monitors, smart insulin pens, and related software.
Read more on MMED →